Your payment is in progress...
  +1 (704) 266-3234

Global Anti-obesity Medicine Market Size, Status And Forecast 2021-2027

Published on: Apr 2021 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 107

Global Anti-obesity Medicine Scope and Market Size
Anti-obesity Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-obesity Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescription Drugs
OTC Drugs

Segment by Application
Men
Women

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alizyme
Amylin Pharmaceuticals
Arena Pharmaceuticals
Boehringer Ingelheim
Eisai
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Pfizer
Roche
Merck
Novo Nordisk

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-obesity Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-obesity Medicine Market Perspective (2016-2027)
2.2 Anti-obesity Medicine Growth Trends by Regions
2.2.1 Anti-obesity Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-obesity Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Anti-obesity Medicine Industry Dynamic
2.3.1 Anti-obesity Medicine Market Trends
2.3.2 Anti-obesity Medicine Market Drivers
2.3.3 Anti-obesity Medicine Market Challenges
2.3.4 Anti-obesity Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-obesity Medicine Players by Revenue
3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2016-2021)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
3.4 Global Anti-obesity Medicine Market Concentration Ratio
3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2020
3.5 Anti-obesity Medicine Key Players Head office and Area Served
3.6 Key Players Anti-obesity Medicine Product Solution and Service
3.7 Date of Enter into Anti-obesity Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-obesity Medicine Breakdown Data by Type
4.1 Global Anti-obesity Medicine Historic Market Size by Type (2016-2021)
4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027)

5 Anti-obesity Medicine Breakdown Data by Application
5.1 Global Anti-obesity Medicine Historic Market Size by Application (2016-2021)
5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-obesity Medicine Market Size (2016-2027)
6.2 North America Anti-obesity Medicine Market Size by Type
6.2.1 North America Anti-obesity Medicine Market Size by Type (2016-2021)
6.2.2 North America Anti-obesity Medicine Market Size by Type (2022-2027)
6.2.3 North America Anti-obesity Medicine Market Size by Type (2016-2027)
6.3 North America Anti-obesity Medicine Market Size by Application
6.3.1 North America Anti-obesity Medicine Market Size by Application (2016-2021)
6.3.2 North America Anti-obesity Medicine Market Size by Application (2022-2027)
6.3.3 North America Anti-obesity Medicine Market Size by Application (2016-2027)
6.4 North America Anti-obesity Medicine Market Size by Country
6.4.1 North America Anti-obesity Medicine Market Size by Country (2016-2021)
6.4.2 North America Anti-obesity Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-obesity Medicine Market Size (2016-2027)
7.2 Europe Anti-obesity Medicine Market Size by Type
7.2.1 Europe Anti-obesity Medicine Market Size by Type (2016-2021)
7.2.2 Europe Anti-obesity Medicine Market Size by Type (2022-2027)
7.2.3 Europe Anti-obesity Medicine Market Size by Type (2016-2027)
7.3 Europe Anti-obesity Medicine Market Size by Application
7.3.1 Europe Anti-obesity Medicine Market Size by Application (2016-2021)
7.3.2 Europe Anti-obesity Medicine Market Size by Application (2022-2027)
7.3.3 Europe Anti-obesity Medicine Market Size by Application (2016-2027)
7.4 Europe Anti-obesity Medicine Market Size by Country
7.4.1 Europe Anti-obesity Medicine Market Size by Country (2016-2021)
7.4.2 Europe Anti-obesity Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-obesity Medicine Market Size (2016-2027)
8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-obesity Medicine Market Size (2016-2027)
9.2 Latin America Anti-obesity Medicine Market Size by Type
9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Anti-obesity Medicine Market Size by Type (2016-2027)
9.3 Latin America Anti-obesity Medicine Market Size by Application
9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Anti-obesity Medicine Market Size by Application (2016-2027)
9.4 Latin America Anti-obesity Medicine Market Size by Country
9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-obesity Medicine Market Size (2016-2027)
10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alizyme
11.1.1 Alizyme Company Details
11.1.2 Alizyme Business Overview
11.1.3 Alizyme Anti-obesity Medicine Introduction
11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2016-2021)
11.1.5 Alizyme Recent Development
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Details
11.2.2 Amylin Pharmaceuticals Business Overview
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.2.5 Amylin Pharmaceuticals Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Anti-obesity Medicine Introduction
11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Details
11.7.2 Orexigen Therapeutics Business Overview
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021)
11.7.5 Orexigen Therapeutics Recent Development
11.8 Vivus
11.8.1 Vivus Company Details
11.8.2 Vivus Business Overview
11.8.3 Vivus Anti-obesity Medicine Introduction
11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2016-2021)
11.8.5 Vivus Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-obesity Medicine Introduction
11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Anti-obesity Medicine Introduction
11.10.4 Roche Revenue in Anti-obesity Medicine Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Anti-obesity Medicine Introduction
11.11.4 Merck Revenue in Anti-obesity Medicine Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021)
11.12.5 Novo Nordisk Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti-obesity Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-obesity Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti-obesity Medicine Market Share by Regions (2016-2021)
Table 8. Global Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Table 10. Anti-obesity Medicine Market Trends
Table 11. Anti-obesity Medicine Market Drivers
Table 12. Anti-obesity Medicine Market Challenges
Table 13. Anti-obesity Medicine Market Restraints
Table 14. Global Anti-obesity Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti-obesity Medicine Market Share by Players (2016-2021)
Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020)
Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-obesity Medicine Product Solution and Service
Table 21. Date of Enter into Anti-obesity Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti-obesity Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2016-2021)
Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alizyme Company Details
Table 62. Alizyme Business Overview
Table 63. Alizyme Anti-obesity Medicine Product
Table 64. Alizyme Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 65. Alizyme Recent Development
Table 66. Amylin Pharmaceuticals Company Details
Table 67. Amylin Pharmaceuticals Business Overview
Table 68. Amylin Pharmaceuticals Anti-obesity Medicine Product
Table 69. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 70. Amylin Pharmaceuticals Recent Development
Table 71. Arena Pharmaceuticals Company Details
Table 72. Arena Pharmaceuticals Business Overview
Table 73. Arena Pharmaceuticals Anti-obesity Medicine Product
Table 74. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 75. Arena Pharmaceuticals Recent Development
Table 76. Boehringer Ingelheim Company Details
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Anti-obesity Medicine Product
Table 79. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 80. Boehringer Ingelheim Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Anti-obesity Medicine Product
Table 84. Eisai Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Anti-obesity Medicine Product
Table 89. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Orexigen Therapeutics Company Details
Table 92. Orexigen Therapeutics Business Overview
Table 93. Orexigen Therapeutics Anti-obesity Medicine Product
Table 94. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 95. Orexigen Therapeutics Recent Development
Table 96. Vivus Company Details
Table 97. Vivus Business Overview
Table 98. Vivus Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 99. Vivus Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Anti-obesity Medicine Product
Table 103. Pfizer Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 104. Pfizer Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Anti-obesity Medicine Product
Table 108. Roche Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Anti-obesity Medicine Product
Table 113. Merck Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 114. Merck Recent Development
Table 115. Novo Nordisk Company Details
Table 116. Novo Nordisk Business Overview
Table 117. Novo Nordisk Anti-obesity Medicine Product
Table 118. Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 119. Novo Nordisk Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-obesity Medicine Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Anti-obesity Medicine Market Share by Application: 2020 VS 2027
Figure 5. Men Case Studies
Figure 6. Women Case Studies
Figure 7. Anti-obesity Medicine Report Years Considered
Figure 8. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Anti-obesity Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-obesity Medicine Market Share by Regions: 2020 VS 2027
Figure 11. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Figure 12. Global Anti-obesity Medicine Market Share by Players in 2020
Figure 13. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2020
Figure 15. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Figure 16. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027)
Figure 17. North America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 19. North America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 20. North America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 21. United States Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 25. Europe Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 26. Europe Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 27. Germany Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Anti-obesity Medicine Market Share by Region (2016-2027)
Figure 37. China Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 45. Latin America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 46. Latin America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 47. Mexico Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 53. Turkey Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 57. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 58. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 60. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 62. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 63. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.